Lyons, CO, United States of America

Kenneth W Hill

USPTO Granted Patents = 2 


Average Co-Inventor Count = 2.4

ph-index = 1


Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Kenneth W. Hill

Introduction

Kenneth W. Hill is a notable inventor based in Lyons, Colorado, recognized for his contributions to the field of oligonucleotide chemistry. With a total of two patents to his name, Hill has made significant advancements in methods for conjugating oligonucleotides, which have important applications in biotechnology and pharmaceuticals.

Latest Patents

Hill's latest patents include innovative methods for the preparation of long synthetic oligonucleotides through squarate conjugation chemistry. One of his patents details a method that involves activating a terminal of a first oligonucleotide using a squarate reagent, leading to the production of an activated first oligonucleotide. This method allows for the binding of the first oligonucleotide and a second oligonucleotide to a splint oligonucleotide, facilitating the conjugation of the activated first oligonucleotide with a terminal of the second oligonucleotide via a squaramide linkage. Additionally, he has developed compositions that include oligonucleotides featuring squaramide internucleoside linkages, which enhance the stability and functionality of these molecules.

Another patent focuses on the synthesis of oligonucleotide derivatives, which includes a method for preparing an oligonucleotide derivative comprising an amino or thiol group. This method utilizes a 3,4-dialkoxycyclobutene-1,2-dione to produce an oligonucleotide-squarate mono-conjugate, showcasing Hill's innovative approach to oligonucleotide chemistry.

Career Highlights

Kenneth W. Hill is currently employed at Agilent Technologies, Inc., where he continues to push the boundaries of oligonucleotide research. His work has contributed to the development of new methodologies that are essential for advancing genetic research and therapeutic applications.

Collaborations

Throughout his career, Hill has collaborated with esteemed colleagues such as Douglas J. Dellinger and Benjamin D. Lunstad. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Kenneth W. Hill's contributions to oligonucleotide chemistry through his patents and work at Agilent Technologies, Inc. highlight his role as a leading inventor in this specialized area. His innovative methods and collaborative efforts continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…